Jennison Associates LLC Legend Biotech Corp Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$23.55 - $32.4 $7.57 Million - $10.4 Million	-321,388 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$25.8 - $32.39 $4.8 Million - $6.03 Million	186,031 Added 137.44%	321,388 $9.05 Million
Q3 2020 Nov 04, 2020	BUY	$27.5 - $39.61 $9,817 - $14,140	357 Added 0.26%	135,357 $4.18 Million
Q2 2020 Aug 06, 2020	BUY	$36.1 - $42.56 $4.87 Million - $5.75 Million	135,000 New	135,000 $5.75 Million

226

74.5M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.18B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.